 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Nabriva Therapeutics plc (NBRV)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-08-21 Sale(A) | 2019-08-26 9:34 pm | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 3,797 | $2.08 | $7,898 | 11,172 (Direct) | View |
| 2019-08-21 Sale(A) | 2019-08-26 9:35 pm | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 3,390 | $2.08 | $7,051 | 19,214 (Direct) | View |
| 2019-08-21 Sale(A) | 2019-08-26 9:35 pm | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 3,797 | $2.08 | $7,898 | 23,239 (Direct) | View |
| 2019-08-21 Sale(A) | 2019-08-26 9:35 pm | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 8,206 | $2.08 | $17,068 | 47,570 (Direct) | View |
| 2019-08-21 Sale(A) | 2019-08-26 9:36 pm | Nabriva Therapeutics plc | NBRV | Broom Colin MD Director | 10,177 | $2.07 | $21,066 | 125,724 (Direct) | View |
| 2019-08-22 Purchase | 2019-08-26 9:49 pm | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 4,800 | $2.037 | $9,780 | 15,972 (Direct) | View |
| 2019-08-27 Purchase | 2019-08-28 4:01 pm | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 50,000 | $1.79 | $89,500 | 117,489 (Direct Indirect) | View |
| 2019-08-30 Purchase | 2019-09-03 4:04 pm | Nabriva Therapeutics plc | NBRV | Broom Colin MD Director | 10,177 | $2.031 | $20,668 | 208,750 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-08-19 Exercise | 2019-08-21 9:22 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Broom Colin MD Director | 33,750 | $0 | 33,750 (Direct) | View |
| 2019-08-19 Tax Withholding | 2019-08-21 9:22 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Broom Colin MD Director | 10,177 | $2.07 | 33,750 (Direct) | View |
| 2019-08-19 Exercise | 2019-08-21 9:22 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Broom Colin MD Director | 33,750 | $0 | 33,750 (Direct) | View |
| 2019-08-19 Exercise | 2019-08-21 9:22 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 11,250 | $0 | 11,250 (Direct) | View |
| 2019-08-19 Tax Withholding | 2019-08-21 9:22 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 3,390 | $2.08 | 11,250 (Direct) | View |
| 2019-08-19 Exercise | 2019-08-21 9:22 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 11,250 | $0 | 11,250 (Direct) | View |
| 2020-01-31 Tax Withholding | 2020-02-04 8:55 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 3,892 | $1.35 | 83,097 (Direct) | View |
| 2020-01-31 Tax Withholding | 2020-02-04 8:55 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 16,276 | $1.35 | 302,760 (Direct) | View |
| 2020-01-31 Tax Withholding | 2020-02-04 8:55 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 3,892 | $1.35 | 75,830 (Direct) | View |
| 2020-01-31 Tax Withholding | 2020-02-04 8:56 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 4,295 | $1.35 | 78,669 (Direct) | View |
| 2020-01-31 Tax Withholding | 2020-02-04 8:56 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 8,651 | $1.35 | 171,919 (Direct) | View |
| 2020-01-31 Tax Withholding | 2020-02-04 8:56 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 4,295 | $1.35 | 53,705 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 8:26 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 105,000 | $0 | 210,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 8:26 pm | N/A 2030-02-05 | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 210,000 | $1.35 | 210,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 8:27 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 343,800 | $0 | 687,500 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 8:27 pm | N/A 2030-02-05 | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 687,500 | $1.35 | 687,500 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 8:28 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 105,000 | $0 | 210,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 8:28 pm | N/A 2030-02-05 | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 210,000 | $1.35 | 210,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 8:29 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 105,000 | $0 | 210,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 8:29 pm | N/A 2030-02-05 | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 210,000 | $1.35 | 210,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 8:30 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 155,000 | $0 | 310,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 8:30 pm | N/A 2030-02-05 | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 310,000 | $1.35 | 310,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 8:30 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 105,000 | $0 | 210,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 8:30 pm | N/A 2030-02-05 | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 210,000 | $1.35 | 210,000 (Direct) | View |
| 2020-02-28 Tax Withholding | 2020-03-03 9:31 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 366 | $1.35 | 199,276 (Direct) | View |
| 2020-02-28 Tax Withholding | 2020-03-03 9:31 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $1.35 | 180,464 (Direct) | View |
| 2020-02-28 Tax Withholding | 2020-03-03 9:31 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $1.35 | 169,949 (Direct) | View |
| 2020-02-28 Tax Withholding | 2020-03-03 9:32 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 301 | $1.35 | 194,281 (Direct) | View |
| 2020-02-28 Tax Withholding | 2020-03-03 9:32 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 606 | $1.35 | 337,858 (Direct) | View |
| 2020-02-28 Tax Withholding | 2020-03-03 9:32 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 1,211 | $1.35 | 651,108 (Direct) | View |
| 2020-03-31 Tax Withholding | 2020-04-02 5:47 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $0.575 | 169,648 (Direct) | View |
| 2020-03-31 Tax Withholding | 2020-04-02 5:48 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 1,211 | $0.575 | 649,897 (Direct) | View |
| 2020-03-31 Tax Withholding | 2020-04-02 5:48 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 366 | $0.575 | 198,883 (Direct) | View |
| 2020-03-31 Tax Withholding | 2020-04-02 5:49 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $0.575 | 180,098 (Direct) | View |
| 2020-03-31 Tax Withholding | 2020-04-02 5:49 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 301 | $0.575 | 193,980 (Direct) | View |
| 2020-03-31 Tax Withholding | 2020-04-02 5:49 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 606 | $0.575 | 337,252 (Direct) | View |
| 2020-04-30 Tax Withholding | 2020-05-04 6:30 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer | 366 | $0.5483 | 179,732 (Direct) | View |
| 2020-04-30 Tax Withholding | 2020-05-04 6:31 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 606 | $0.5483 | 336,646 (Direct) | View |
| 2020-04-30 Tax Withholding | 2020-05-04 6:31 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 1,211 | $0.5483 | 648,686 (Direct) | View |
| 2020-04-30 Tax Withholding | 2020-05-04 6:32 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $0.5483 | 169,347 (Direct) | View |
| 2020-04-30 Tax Withholding | 2020-05-04 6:32 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 301 | $0.5483 | 193,679 (Direct) | View |
| 2020-04-30 Tax Withholding | 2020-05-04 6:33 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 366 | $0.5483 | 198,517 (Direct) | View |